Clinical Trials Browser

Phase 1 × OTHER × Hyperandrogenism × Clear all

NCT01428089 2023-11-02

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

Phase 1 Unknown

Polycystic Ovary Syndrome, Hyperandrogenism

NCT01489319 2017-02-10

ELI-ROAS

Phase 1 Terminated

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism